-
rel-N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide
-
BD013725212193462-87-097%
-
¥342.025mg
-
N-(2-(1H-Indol-3-yl)ethyl)acetamide
-
BD1430761016-47-398%
-
¥385.01g
-
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
-
BD1479673-31-497%
-
¥38.05g
-
(S)-N-(2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide
-
BD150225196597-26-998%
-
¥583.0100mg
-
N-(2-(2-Benzyl-1H-indol-3-yl)ethyl)acetamide
-
BD136882117946-91-598%
-
¥1333.025mg
-
N-(2-(2-Iodo-5-methoxy-1H-indol-3-yl)ethyl)acetamide
-
BD0116159793515-00-598%
-
¥1075.050mg
-
GR 196429
-
BD01910091170729-12-198%
-
¥
-
N-(2-(5-Ethylbenzo[b]thiophen-3-yl)ethyl)acetamide
-
BD01369263180304-07-898%
-
¥
-
N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propionamide
-
BD00783402134865-74-098%
-
¥2244.025mg
-
Melatonin-d7
-
BD01227782615251-68-898% 98%atom%D
-
¥
-
Melatonin receptor agonist 1
-
BD015412772411150-76-898%
-
¥
-
Ramelteon metabolite M-II-d3
-
BD012138851246812-22-598% +98%atom%D
-
¥
-
7-Desmethyl-3-hydroxyagomelatine
-
BD01322854166527-00-098%
-
¥
-
2-Hydroxy-N-(2-((S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propanamide
-
BD01130291896736-21-399+%
-
¥
-
GR 128107
-
BD01881446190328-44-098%
-
¥
-
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl-1,1,2,2-d4)acetamide
-
BD0113582066521-38-898% 98%atom%D
-
¥1712.01mg